Home › Burkitt-lymfoom › Virginia
Burkitt-lymfoom klinische studies in Virginia
7 studies voor Burkitt-lymfoom zoeken deelnemers op locaties in Virginia.
Steden in Virginia
Officiële studietekst (Engels)
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
- University of Virginia Cancer Center, Charlottesville
- Inova Fairfax Hospital, Falls Church
- Children's Hospital of The King's Daughters, Norfolk
- en nog 2
RekruterenFase 2
366 Days – 46 Years · Alle geslachten · Bijgewerkt 2 okt. 2026 · NCT06124157Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
- VCU Massey Comprehensive Cancer Center, Richmond
RekruterenFase 3
Leeftijden 18 tot 39 · Alle geslachten · Bijgewerkt 2 okt. 2026 · NCT03150693Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- VCU Massey Comprehensive Cancer Center, Richmond
RekruterenFase 2
Leeftijden 18 en ouder · Alle geslachten · Bijgewerkt 29 sep. 2026 · NCT03739814Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
- University of Virginia Cancer Center, Charlottesville
- Children's Hospital of The King's Daughters, Norfolk
- VCU Massey Comprehensive Cancer Center, Richmond
- en nog 1
RekruterenFase 2
365 Days · Alle geslachten · Bijgewerkt 25 sep. 2026 · NCT06317662A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
- Inova Fairfax Hospital, Falls Church
- Children's Hospital of The King's Daughters, Norfolk
- VCU Massey Comprehensive Cancer Center, Richmond
RekruterenFase 2
Leeftijden 1 tot 30 · Alle geslachten · Bijgewerkt 1 sep. 2026 · NCT04546399Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
- University of Virginia Cancer Center, Charlottesville
- Inova Fairfax Hospital, Falls Church
- Children's Hospital of The King's Daughters, Norfolk
- en nog 3
RekruterenFase 3
365 Days – 25 Years · Alle geslachten · Bijgewerkt 25 aug. 2026 · NCT03959085AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
- Research Site, Richmond
RekruterenFase 1/2
Leeftijden 12 en ouder · Alle geslachten · Bijgewerkt 19 aug. 2026 · NCT06137118Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.